David Faleck, a Principal Investigator at Memorial Sloan Kettering Cancer Center, is collaborating with a company to develop treatments for ICI side effects.
1 report, 1 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
David Faleck, a Principal Investigator at Memorial Sloan Kettering Cancer Center, is collaborating with a company to develop treatments for ICI side effects.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Memorial Sloan Kettering Cancer Center
cancer treatment and research institution in New York City, United States
-
ICI
programming language
Nothing else this week.